GGrantIndex
← Leaderboards

Weiva Sieh

University Of Tx Md Anderson Can Ctr

$5,441,975
Attributed
$10,354,624
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,354,624 · 6

By mechanism

R01$9,135,032 · 4
K07$866,902 · 1
R21$352,690 · 1

Top collaborators

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Cohort

Research focus

CohortPopulation BasedDiagnosisGenesGenome Wide Association StudyMalignant NeoplasmsCessation Of LifeTissuesCharacteristicsWomanMalignant Breast NeoplasmCost EfficientCostGenotypeVariantCause Of DeathUnited States National Institutes Of HealthGeneticInnovationRaceSample SizeFollow-UpInternationalEnvironment

Grant awards (26)

Radiomic and genomic predictors of breast cancer risk$697,652
R01 · FY2025 · CA · contact PI
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners$293,618
R01 · FY2025 · CA
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners$203,294
R01 · FY2025 · CA
Radiomic and genomic predictors of breast cancer risk$662,768
R01 · FY2024 · CA · contact PI
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners$472,066
R01 · FY2024 · CA
Genomic and Transcriptomic Analysis of Mammographic Density$495,945
R01 · FY2023 · CA · contact PI
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners$418,130
R01 · FY2023 · CA
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners$141,103
R01 · FY2023 · CA
Radiomic and genomic predictors of breast cancer risk$681,064
R01 · FY2022 · CA · contact PI
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners$564,258
R01 · FY2022 · CA
Genomic and Transcriptomic Analysis of Mammographic Density$474,559
R01 · FY2022 · CA · contact PI
Radiomic and genomic predictors of breast cancer risk$712,593
R01 · FY2021 · CA · contact PI
Genomic and Transcriptomic Analysis of Mammographic Density$484,243
R01 · FY2021 · CA · contact PI
Genomic and Transcriptomic Analysis of Mammographic Density$501,617
R01 · FY2020 · CA · contact PI
Discovering and Characterizing Novel Pregnancy-Associated Cancers$150,017
R21 · FY2017 · CA
Genome-Wide Association Study of Mammographic Density$284,499
R01 · FY2016 · CA · contact PI
Discovering and Characterizing Novel Pregnancy-Associated Cancers$202,673
R21 · FY2016 · CA
Genome-Wide Association Study of Mammographic Density$528,086
R01 · FY2015 · CA · contact PI
Genome-Wide Association Study of Mammographic Density$316,405
R01 · FY2014 · CA · contact PI
Genetic Epidemiology of Ovarian and Prostate Cancer$173,335
K07 · FY2014 · CA · contact PI
Genome-Wide Association Study of Mammographic Density$585,178
R01 · FY2013 · CA · contact PI
Genetic Epidemiology of Ovarian and Prostate Cancer$173,223
K07 · FY2013 · CA · contact PI
Genome-Wide Association Study of Mammographic Density$617,954
R01 · FY2012 · CA · contact PI
Genetic Epidemiology of Ovarian and Prostate Cancer$173,448
K07 · FY2012 · CA · contact PI
Genetic Epidemiology of Ovarian and Prostate Cancer$173,448
K07 · FY2011 · CA · contact PI
Genetic Epidemiology of Ovarian and Prostate Cancer$173,448
K07 · FY2010 · CA · contact PI